Medtronic Settles Patent Dispute With Cytomedix
Cytomedix sued Medtronic in U.S. District Court for the District of Maryland in November, claiming that Medtronic was infringing Cytomedix's patent for a technology that uses the platelets in a person's blood to help the body heal itself.
The technology is used in treating tissue damage or diabetic foot ulcers.
Cytomedix indicated that it expects...
To view the full article, register now.